Ramsay Healthcare – Buy
Ramsay Health Care is under Algo Engine buy conditions and is a current holding in our model portfolio.
8% Cash Flow From Healthcare
Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Ramsay Healthcare
Ramsay Healthcare
RHC delivered 8% revenue growth in FY20, with a strong 1H more than offsetting the 4% decline experienced in 2H.
Australia suffered the greatest contraction in 2H, down 8% on the same time last year. UK revenue growth remained solid, up almost 5%.
Based on normalization in FY22 earnings, we have the stock trading on a forward yield of 2.2%.
Ramsay Healthcare – Buy
Buy Ramsay Health Care within the $61 – $65 price range.
Ramsay Health Care – Rallies 10%
Ramsay Health Care is faced with flat earnings in 2020 and only moderate growth FY21. For patient long-term investors, there’s an income opportunity with defensive low levels of growth.
We see buying support increasing near the $60 level.
The above post is from early August when RHC was trading in the $60 – $62 price range. The stock is now approaching $70 and short-term traders can consider taking profit between $68 – $70.
Ramsay Health Care – Buy
Ramsay Health Care is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
We see value emerging and suggest accumulating within the $50 – $52 price range.
Ramsay – Approaching Support
Ramsay Health Care is under Algo Engine buy conditions and is a current holding in our ASX 100 model.
We see Ramsay Healthcare as a defensive position within the current volatile market conditions.
Buying support should develop within the $52 to $56 price band.
Ramsay Healthcare – Buy Signal
Ramsay Health Care is under Algo Engine buy conditions and has now been added into the ASX 100 model portfolio.
We see price support developing near $62, following Ramsay Health Care advising that Paul Ramsay Holdings has completed the underwritten block trade sale of 22m shares in the Company to institutional investors at $61.80 per share.
Buy RHC at $62.00
Ramsay Healthcare – Valuation Review
Ramsay Health Care is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
RHC trades on 21x forward earnings, dividend yield of 2.4% and underlying EPS growth into FY20 of 2 – 4 %. Forecast FY20 revenue $13bn, EBIT $1.2bn, EPS $3.00 & DPS $1.55.
In a low rate environment, we see the new trading range for Ramsay within the $65 – $70 band.
We see buying support building at the $64 price level.
Level 29 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453